Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule
Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Amyotrophic lateral sclerosis (ALS) is one of the most devastating neurodegenerative diseases. Neurotrophic factors have been widely tested to counteract neurodegenerative conditions, despite their unspecific neuronal access. The non-toxic C-terminal fragment of the tetanus toxin (TTC) heavy chain has been studied not only as a carrier molecule to...
Alternative Titles
Full title
Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8d134c6cf0634a12a8cfde925e08138d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8d134c6cf0634a12a8cfde925e08138d
Other Identifiers
ISSN
1750-1172
E-ISSN
1750-1172
DOI
10.1186/1750-1172-6-10
